Jaguar Health, Inc. Business Operations Contracts & Agreements
24 Contracts & Agreements
- Advisory Agreements (1 contract)
- Agency Agreements (3)
- Collaboration Agreements (1)
- Distribution Agreements (1)
- Indemnification Agreements (1)
- Management Agreements (1)
- MOUs (1)
- Services Agreements (3)
- Settlement Agreements (4)
- Supply Agreements (5)
- Termination Agreements (3)
- Amendment No. 1 to Manufacturing and Supply Agreement, dated July 12, 2023, by and between Napo Pharmaceuticals, Inc. and Glenmark Life Sciences Limited (Filed With SEC on August 14, 2023)
- Binding Memorandum of Understanding, dated June 30, 2023, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., Iliad Research and Trading, L.P., Uptown Capital, LLC and... (Filed With SEC on August 14, 2023)
- Mutual Termination of License Agreement, dated as of January 31, 2023, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD, and Tao Wang (Filed With SEC on February 6, 2023)
- Manufacturing Services Agreement, dated June 10, 2022, by and between Napo Pharmaceuticals, Inc. and Patheon Pharmaceuticals Inc (Filed With SEC on August 24, 2022)
- Certain information marked as [****] has been excluded from this exhibit because it is both (i)not material and (ii)would be competitively harmful if publicly disclosed.... (Filed With SEC on May 17, 2021)
- Placement Agency Agreement, dated April 29, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 30, 2021)
- Master Services Agreement, dated October 5, 2020, by and between Napo Pharmaceuticals, Inc. and Integrium, LLC (Filed With SEC on March 31, 2021)
- Master Services Agreement, dated June 24, 2019, by and among Napo Pharmaceuticals, Inc., Integrium, LLC, and POC Capital, LLC (Filed With SEC on March 31, 2021)
- Placement Agency Agreement, dated January 13, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on January 14, 2021)
- Manufacturing and Supply Agreement, dated September 3, 2020, by and between Glenmark Life Sciences Limited and Napo Pharmaceuticals, Inc (Filed With SEC on November 16, 2020)
- Fee Settlement Agreement, dated October 7, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC (Filed With SEC on October 9, 2020)
- China Life Science Advisory Agreement, dated October 8, 2019, by and between Jaguar Health, Inc. and Angel Pond Capital LLC (Filed With SEC on October 22, 2019)
- License Termination and Settlement Agreement, dated October 1, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Michael Tempesta (Filed With SEC on October 7, 2019)
- Placement Agency Agreement, dated March 24, 2019, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on March 25, 2019)
- Suspension, Settlement and Termination Agreement, dated December 4, 2018, by and among Napo Pharmaceuticals, Inc., Jaguar Health, Inc. and SmartPharma, LLC (Filed With SEC on December 10, 2018)
- Collaboration Agreement, dated December 13, 2017, by and between Jaguar Health, Inc. and Seed Mena Businessmen Services, LLC (Filed With SEC on April 9, 2018)
- Management Services Agreement, dated March 23, 2018, by and between Jaguar Health, Inc. and Sagard Capital Partners Management Corp (Filed With SEC on March 27, 2018)
- DEBT SETTLEMENT AGREEMENT (Filed With SEC on April 18, 2017)
- DEBT SETTLEMENT AGREEMENT (Filed With SEC on April 18, 2017)
- SETTLEMENT AND DISCOUNTED PAYOFF AGREEMENT (Filed With SEC on April 18, 2017)
- *** TEXT OMITTED AND SUBMITTED PURSUANT TO CONFIDENTIAL TREATMENT REQUEST DISTRIBUTION AGREEMENT (Filed With SEC on February 15, 2017)
- Patheon Pharmaceuticals Inc. (Patheon) Jaguar Animal Health (Client) By: /s/ Francis P. McCone By: /s/ Steven R. King Name: Francis P. McCone Name: Steven R. King Title: Secretary... (Filed With SEC on January 7, 2016)
- MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on November 13, 2015)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on August 27, 2014)
